Genomma Lab Internacional S.A.B. de C.V. is a pharmaceutical company that develops, manufactures, and markets a diverse portfolio of over-the-counter medicines, personal care products, and consumer health solutions primarily in Mexico and select international markets. Its product lineup includes treatments for common ailments such as digestive issues, pain relief, dermatological conditions, vitamins, supplements, and hygiene items, all designed for self-medication and everyday wellness needs. The company emphasizes branded generics and innovative formulations tailored to consumer preferences in Latin America, distributing through pharmacies, supermarkets, mass retailers, and e-commerce platforms. Genomma Lab Internacional S.A.B. de C.V. operates in the competitive consumer healthcare sector, focusing on accessible, high-quality products that address prevalent health and beauty concerns. Founded in 1996 and headquartered in Mexico City, Mexico, it plays a key role in providing affordable healthcare options to millions of households across its operational regions.
Markedsdata leveret af TwelveData og Morningstar
Baseret på 5 analytikere